- Home
- Equipment
- north korea
- nanoparticle
Show results for
Refine by
Nanoparticle Equipment & Supplies In North Korea
53 equipment items found
Manufactured by:Camurus AB based inLund, SWEDEN
FluidCrysta nanoparticles can resolve bioavailability issues for water and lipid-soluble pharmaceuticals or biodegradation-sensitive drugs, such as peptides and proteins. FluidCrystal nanoparticles are usually water-based and comprise a stable emulsion of nanoparticles with a liquid crystalline structure. ...
Manufactured by:Novavax based inGaithersburg, MARYLAND (USA)
Our recombinant nanoparticle vaccine technology combines the power and speed of genetic engineering to efficiently produce a new class of highly immunogenic particles that target a variety of viral pathogens. Our recombinant vaccine engineering takes a new approach to provide robust and functional immunity, which may be more efficacious than naturally occurring immunity or ...
Manufactured by:PreciGenome LLC based inSan Jose, CALIFORNIA (USA)
NanoGenerator™ Flex-S Plus is a high-performance formulation screening platform for nanoparticles synthesis such as lipid nanoparticles(LNP), liposomes, PLGA, etc. Especially, it is the screening platform with high-throughput up to 48-96 samples per run for automatic screening of LNP formulation, which is widely used for mRNA LNP vaccines. ...
Manufactured by:nanoTherics Ltd. based inWarrington, UNITED KINGDOM
This option enables the study of mediated nanoparticles in an alternating magnetic field utilizing the magneTherm System. ...
Manufactured by:nanoPET Pharma GmbH based inBerlin, GERMANY
Viscover™ provides you with the first dedicated product portfolio of animal contrast agents to unleash the full potential of pre-clinical animal MRI, employing innovative agents from small molecules to nanoparticles. Our GadoSpin™ gadolinium chelate and FeraSpin™ iron oxide nanoparticle product families were designed to offer you previously ...
by:Taiwan Liposome Company, Ltd. (TLC) based inNangang Distric, TAIWAN
TLC has a proprietary solution for pharmaceutical product development called NanoX®. NanoX® technology uses nanoparticles coated with the compound polyethylene glycol to reduce uptake by phagocytic cells of the immune system. This prolongs circulation in the body, allowing a drug to predominantly accumulate at particular disease sites such as tumors. Therapies based on ...
Manufactured by:Unchained Labs based inPleasanton, CALIFORNIA (USA)
Dig in to your AAV to get the total capsid titer and empty/full ratio, or rack up payload concentration and size data on any nanoparticle all at once. Nail down your protein quality by knocking concentration, hydrodynamic size, polydispersity, and detection of aggregates off your list in one shot. Without skipping a beat, you’ll know if your AAV, ...
by:Myeloid Therapeutics based inCambridge, MASSACHUSETTS (USA)
Myeloid’s novel in vivo engineering platform specifically targets and activates myeloid cells to elicit broader anti-tumor adaptive immunity. Through this approach, Myeloid demonstrates that delivery of lipid-nanoparticles (LNPs) encapsulating mRNA results in uptake and selective expression by myeloid cells in vivo, leading to potent tumor killing in multiple cold tumor ...
Manufactured by:Evox Therapeutics Limited based inOxford, UNITED KINGDOM
Targeted delivery of nanoparticles is an area that has been intensively researched. Targeted drug delivery has a role to play in the delivery of many if not all drugs, but targeted delivery systems are critical for the delivery of nucleic acid-based agents such as siRNA and CRISPR-Cas ...
Manufactured by:Ellume Limited based inEast Brisbane, AUSTRALIA
Our patented detection method uses unique fluorescent nanoparticles and a sophisticated reader system to achieve accurate results from a clinical sample within minutes. We create efficiencies using our platform technology across a range of diagnostic tests for consumers, healthcare professionals at the point-of-care and higher-throughput laboratories. ...
by:Taiwan Liposome Company, Ltd. (TLC) based inNangang Distric, TAIWAN
By encapsulating molecules with poor solubility in polymeric micelle nanoparticles, TLC’s technology can increase the solubility of a drug. This allows a larger quantity to be delivered in a single dose, which can enable new forms of administration. For molecules that are too insoluble to be practical as stand-alone therapies, lipid encapsulation may be the key to ...
Manufactured by:Blueberry Therapeutics based inCheshire, UNITED KINGDOM
To address this problem, our unique drug formulations use a nanopolymer called Nanocin™, which when mixed with the active drug under the right conditions, forms complexes that then aggregate into nanoparticles, enabling enhanced delivery through the skin or ...
by:Myeloid Therapeutics based inCambridge, MASSACHUSETTS (USA)
Emerging from the Company’s proprietary ATAK™ CAR receptor library, Myeloid’s novel in vivo engineering platform specifically targets and activates myeloid cells to elicit broader anti-tumor adaptive immunity. Through this approach, Myeloid demonstrates that delivery of lipid-nanoparticles (LNPs) encapsulating mRNA results in uptake and selective expression by ...
Manufactured by:In-Tox Products, LLC based inClinton, MISSISSIPPI (USA)
It is a highly configurable platform that is used to expose cell cultures and tissues to gases and vapors, aerosolized bacterial cells and spores, fungi, viruses, fibers, nanoparticles, and chemical test articles. Primary epithelial lung cells may be used to investigate pulmonary host responses. Additionally, dermal and corneal/scleral cell cultures may be used for external ...
by:Starpharma Holdings Limited based inMelbourne, AUSTRALIA
Dendrimers are precise, synthetically manufactured, nanoscale molecules with unique properties that make them useful to the health and pharmaceutical industry to enhance existing products and as entirely new products. Starpharma's dendrimer technology allows the creation of specifically defined nanoparticles that are applicable to a wide range of medical uses. Starpharma uses its ...
Manufactured by:AstraZeneca based inCambridge, UNITED KINGDOM
Developed using cutting-edge structure-based design techniques at the Institute for Protein Design at the UW School of Medicine, IVX-411, our lead vaccine candidate for COVID-19, is a self-assembling protein nanoparticle that displays 60 copies of the SARS-CoV-2 spike (S) glycoprotein receptor-binding domain (RBD) in a highly immunogenic ...
by:Starpharma Holdings Limited based inMelbourne, AUSTRALIA
DEP® irinotecan is an improved version of irinotecan (Camptosar®), predominantly used for colorectal cancer. DEP® irinotecan is a novel, patented nanoparticle formulation of SN-38, the active metabolite of irinotecan, delivered using Starpharma’s proprietary DEP® technology. Irinotecan (Camptosar®) is a major cancer drug used to treat colorectal cancer ...
Manufactured by:Bilix Co., Ltd. based inYongin, SOUTH KOREA
Many inflammatory diseases are associated with reactive oxygen species(ROS) in the body. The bilirubin nanoparticle has strong antioxidant, ROS scavenging, and immune modulating properties which effectively eliminate the disease-causing ...
Manufactured by:Novavax based inGaithersburg, MARYLAND (USA)
In March 2020, we announced positive top-line results from our Phase 3 clinical trial of our nanoparticle seasonal quadrivalent influenza vaccine candidate, including our proprietary Matrix-M™ adjuvant (NanoFlu™). The trial was a randomized, observer-blinded, active-controlled trial in approximately 2,652 healthy older adults (aged 65 years and older) across 19 ...
Manufactured by:Virpax Pharmaceuticals based inBerwyn, PENNSYLVANIA (USA)
Using a novel encapsulation method known as Molecular Envelope Technology (MET), leucine-enkephalin, or L-ENK can be delivered via an intranasal formulation of “protected” nanoparticles. MET increases dwell time in the nares promoting delivery via the olfactory route across the blood brain barrier and into the central nervous ...